tiprankstipranks
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market
2157
Lepu Biopharma Co. Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2157 full AI Analyst Report?

Lepu Biopharma Co. Ltd. Class H (2157) Income Statement

4 Followers

Lepu Biopharma Co. Ltd. Class H Income Statement

Last quarter (Q4 2025), Lepu Biopharma Co. Ltd. Class H's total revenue was ¥461.10M, an increase of 543.95% from the same quarter last year. In Q4, Lepu Biopharma Co. Ltd. Class H's net income was ¥215.95M. See Lepu Biopharma Co. Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 910.67M¥ 367.79M¥ 225.35M¥ 15.57M¥ 0.00
Gross Profit
¥ 732.10M¥ 292.97M¥ 197.07M¥ 13.57M¥ 0.00
Operating Expenses
¥ 644.67M¥ 683.74M¥ 192.28M¥ 718.05M¥ 1.01B
Depreciation and Amortization
¥ 91.30M¥ 83.91M¥ 102.57M¥ 95.45M¥ 77.18M
EBITDA
¥ 178.73M¥ -311.94M¥ 86.95M¥ -596.53M¥ -865.23M
Operating Income
¥ 87.43M¥ -390.76M¥ 4.80M¥ -704.48M¥ -1.01B
Other Income/Expenses
¥ 166.46M¥ -33.43M¥ -35.10M¥ 5.04M¥ -19.23M
Pretax Income
¥ 253.89M¥ -424.19M¥ -30.30M¥ -699.44M¥ -1.03B
Net Income
¥ 254.60M¥ -411.38M¥ -22.10M¥ -689.05M¥ -1.01B
Per Share Metrics
Basic EPS
¥ 0.14¥ -0.24¥ -0.01¥ -0.42¥ -0.61
Diluted EPS
¥ 0.14¥ -0.24¥ -0.01¥ -0.42¥ -0.61
Weighted Average Shares Outstanding
 1.76B 1.69B 1.66B 1.64B 1.66B
Weighted Average Shares Outstanding (Diluted)
 1.76B 1.69B 1.66B 1.64B 1.66B
Currency in CNY

Lepu Biopharma Co. Ltd. Class H Earnings and Revenue History